Jane Turner1,2, Patsy Yates3, Lizbeth Kenny4,5, Louisa G Gordon6, Bryan Burmeister7, Brett G M Hughes4,5, Alexandra L McCarthy8,9, Chris Perry8, Raymond J Chan3,8, Alana Paviour5, Helen Skerman3, Martin Batstone4,5, Lisa Mackenzie4. 1. Faculty of Medicine, University of Queensland, Brisbane, Australia. jane.turner@uq.edu.au. 2. Royal Brisbane and Women's Hospital, Brisbane, Australia. jane.turner@uq.edu.au. 3. Queensland University of Technology, Brisbane, Australia. 4. Faculty of Medicine, University of Queensland, Brisbane, Australia. 5. Royal Brisbane and Women's Hospital, Brisbane, Australia. 6. QIMR Berghofer Medical Research Institute, Brisbane, Australia. 7. GenesisCare, Fraser Coast, Australia. 8. Princess Alexandra Hospital, Brisbane, Australia. 9. School of Nursing, University of Auckland, Auckland, New Zealand.
Abstract
PURPOSE: A randomised controlled trial was conducted to evaluate the effectiveness of a nurse-delivered Head and Neck Cancer Survivor Self-Management Care Plan (HNCP) for patients who had completed treatment for head and neck cancer (HNC). METHODS: Ten oncology nurses were trained to deliver the HNCP. The HNCP consisted of one face-to-face hour-long meeting in which the patient's treatment was recorded, as were contact details of health professionals involved in their care and follow-up schedules. Patients were guided to nominate up to three goals for their future well-being and assisted to devise an action plan to achieve these. The HNCP was given to the patient and a copy was forwarded to their primary care physician. One hundred and nine patients were randomised after definitive curative intent treatment, 36 to HNCP, 36 to receive information about survivorship, and 37 to usual care. The primary outcome, analysed by intention-to-treat, was change in quality of life measured by the FACT-H&N from baseline to 6-month follow-up. RESULTS:Quality of life of all groups decreased at 3 months but was close to baseline at 6 months. Compared with the usual care group, the only statistically significant mean difference at 6 months was for the information group on the physical well-being domain (mean difference 0.4, 95% - 1.8, 2.6, p < 0.05). CONCLUSIONS: A single-session nurse-delivered intervention is insufficient to improve the quality of life in HNC survivors compared with usual care. Provision of detailed written information about HNC survivorship is associated with improved physical well-being. TRIAL REGISTRATION: ACTRN12613000542796.
RCT Entities:
PURPOSE: A randomised controlled trial was conducted to evaluate the effectiveness of a nurse-delivered Head and Neck Cancer Survivor Self-Management Care Plan (HNCP) for patients who had completed treatment for head and neck cancer (HNC). METHODS: Ten oncology nurses were trained to deliver the HNCP. The HNCP consisted of one face-to-face hour-long meeting in which the patient's treatment was recorded, as were contact details of health professionals involved in their care and follow-up schedules. Patients were guided to nominate up to three goals for their future well-being and assisted to devise an action plan to achieve these. The HNCP was given to the patient and a copy was forwarded to their primary care physician. One hundred and nine patients were randomised after definitive curative intent treatment, 36 to HNCP, 36 to receive information about survivorship, and 37 to usual care. The primary outcome, analysed by intention-to-treat, was change in quality of life measured by the FACT-H&N from baseline to 6-month follow-up. RESULTS: Quality of life of all groups decreased at 3 months but was close to baseline at 6 months. Compared with the usual care group, the only statistically significant mean difference at 6 months was for the information group on the physical well-being domain (mean difference 0.4, 95% - 1.8, 2.6, p < 0.05). CONCLUSIONS: A single-session nurse-delivered intervention is insufficient to improve the quality of life in HNC survivors compared with usual care. Provision of detailed written information about HNC survivorship is associated with improved physical well-being. TRIAL REGISTRATION: ACTRN12613000542796.
Entities:
Keywords:
Head and neck cancer; Self-management; Survivorship
Authors: Susan Yount; Marcy List; Hongyan Du; Kathleen Yost; Rita Bode; Bruce Brockstein; Athanassios Argiris; Everett Vokes; Ezra E W Cohen; Bruce Campbell; Veronica Valenzuela; Jacquelyn George; Robyn Egan; Jessica Chen; David Meddis; David Cella Journal: Qual Life Res Date: 2007-10-06 Impact factor: 4.147
Authors: Paul B Jacobsen; Antonio P DeRosa; Tara O Henderson; Deborah K Mayer; Chaya S Moskowitz; Electra D Paskett; Julia H Rowland Journal: J Clin Oncol Date: 2018-05-18 Impact factor: 44.544
Authors: Jacqueline de Leeuw; Judith B Prins; Steven Teerenstra; Matthias A W Merkx; Henri A M Marres; Theo van Achterberg Journal: Support Care Cancer Date: 2012-08-04 Impact factor: 3.603
Authors: Ahmedin Jemal; Edgar P Simard; Christina Dorell; Anne-Michelle Noone; Lauri E Markowitz; Betsy Kohler; Christie Eheman; Mona Saraiya; Priti Bandi; Debbie Saslow; Kathleen A Cronin; Meg Watson; Mark Schiffman; S Jane Henley; Maria J Schymura; Robert N Anderson; David Yankey; Brenda K Edwards Journal: J Natl Cancer Inst Date: 2013-01-07 Impact factor: 13.506
Authors: S Singer; S Kuhnt; H Götze; J Hauss; A Hinz; A Liebmann; O Krauss; A Lehmann; R Schwarz Journal: Br J Cancer Date: 2009-02-24 Impact factor: 7.640
Authors: Claire Snyder; Youngjee Choi; Katherine C Smith; Renee F Wilson; Christina T Yuan; Paul C Nathan; Allen Zhang; Karen A Robinson Journal: JNCI Cancer Spectr Date: 2022-03-02
Authors: Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver Journal: Contemp Clin Trials Date: 2021-05-21 Impact factor: 2.261
Authors: Erin L O'Hea; Samantha Creamer; Julie M Flahive; Beth A Keating; Candace R Crocker; Shannon R Williamson; Kathryn L Edmiston; Tina Harralson; Edwin D Boudreaux Journal: J Psychosoc Oncol Date: 2021-06-20